Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Clinical characteristics and the course of hepatobiliary and pancreatic malignant tumors with high microsatellite instability after pembrolizumab administration: A multicenter observational study.
Authors
Yuta Maruki
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
Yuta Maruki , Kenji Ikezawa , Mitsuhito Sasaki , Satoshi Kobayashi , Akiko Todaka , Hidetaka Tsumura , Naohiro Okano , Takeshi Terashima , Tatsuya Yamashita , Yasuyuki Kawamoto , Yasushi Kojima , Hiroshi Imaoka , Hiroko Hosoi , Chigusa Morizane , Makoto Ueno , Masafumi Ikeda , Takuji Okusaka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Clinical Trial Registration Number
UMIN000040591
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 459)
DOI
10.1200/JCO.2024.42.3_suppl.459
Abstract #
459
Poster Bd #
B4
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Final outcomes of a phase 2 trial.
First Author: Robin Kate Kelley
Poster
2023 ASCO Gastrointestinal Cancers Symposium
MSI exploration in patients with biliary tract cancer from the Spanish RETUD Registry.
First Author: Andrés J. Muñoz Martín Sr.
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Does detection of microsatellite instability-high (MSI-H) by plasma-based testing predict tumor response to immunotherapy (IO) in patients with pancreatic cancer (PC)?
First Author: Sakti Chakrabarti
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of chemotherapy for patients with unresectable pancreatic cancer concomitant with collagen disease: A multicenter retrospective observational study.
First Author: Hiroyuki Asama